{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:24:46Z","timestamp":1758479086516,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA039195","F31DA046121"],"award-info":[{"award-number":["DA039195","F31DA046121"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM106999"],"award-info":[{"award-number":["GM106999"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00213-020-05558-0","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:02:42Z","timestamp":1591304562000},"page":"2613-2620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine"],"prefix":"10.1007","volume":"237","author":[{"given":"Samantha J.","family":"McClenahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda G.","family":"Gunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Michael","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Fantegrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"5558_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Huang PK, Creehan KM et al (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130\u2013140. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.003","journal-title":"Neuropharmacology"},{"key":"5558_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u201cbath salts\u201d products. Neuropsychopharmacol 38:552\u2013562. https:\/\/doi.org\/10.1038\/npp.2012.204","journal-title":"Neuropsychopharmacol"},{"key":"5558_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7854_2016_53","volume-title":"Neuropharmacology of new psychoactive substances (NPS)","author":"MH Baumann","year":"2016","unstructured":"Baumann MH, Bukhari MO, Lehner KR et al (2016) Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs. In: Neuropharmacology of new psychoactive substances (NPS). Springer, Cham, pp 93\u2013117. https:\/\/doi.org\/10.1007\/7854_2016_53"},{"key":"5558_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/(ISSN)2052-1707","volume":"291","author":"SB Caine","year":"1999","unstructured":"Caine SB, Negus SS, Mello NK, Bergman J (1999) Effects of dopamine D1-like and D2-likeagonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353\u2013360. https:\/\/doi.org\/10.1002\/(ISSN)2052-1707","journal-title":"J Pharmacol Exp Ther"},{"key":"5558_CR5","doi-asserted-by":"crossref","unstructured":"Caine SB, Bowen CA, Yu G, Zuzga D (2004) Effect of gonadectomy and gonadal hormone replacement on cocaine self-administration in female and male rats - ProQuest.","DOI":"10.1038\/sj.npp.1300387"},{"key":"5558_CR6","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","volume":"27","author":"MJ Duryee","year":"2009","unstructured":"Duryee MJ, Bevins RA, Reichel CM et al (2009) Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine 27:2981\u20132988. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.105","journal-title":"Vaccine"},{"key":"5558_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/npp.2012.233","volume":"38","author":"WE Fantegrossi","year":"2013","unstructured":"Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacol 38:563\u2013573. https:\/\/doi.org\/10.1038\/npp.2012.233","journal-title":"Neuropsychopharmacol"},{"key":"5558_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1124\/jpet.115.229500","volume":"356","author":"BM Gannon","year":"2016","unstructured":"Gannon BM, Williamson A, Suzuki M et al (2016) Stereoselective effects of abused \u201cbath salt\u201d constituent 3,4-methylenedioxypyrovalerone in mice: drug discrimination, locomotor activity, and thermoregulation. J Pharmacol Exp Ther 356:615\u2013623. https:\/\/doi.org\/10.1124\/jpet.115.229500","journal-title":"J Pharmacol Exp Ther"},{"key":"5558_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/jpet.116.239376","volume":"361","author":"BM Gannon","year":"2017","unstructured":"Gannon BM, Galindo KI, Rice KC, Collins GT (2017) Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats. J Pharmacol Exp Ther 361:181\u2013189. https:\/\/doi.org\/10.1124\/jpet.116.239376","journal-title":"J Pharmacol Exp Ther"},{"key":"5558_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15563650.2018.1533727","volume":"56","author":"DD Gummin","year":"2018","unstructured":"Gummin DD, Mowry JB, Spyker DA et al (2018) 2017 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol 56:1213\u20131415. https:\/\/doi.org\/10.1080\/15563650.2018.1533727","journal-title":"Clin Toxicol"},{"key":"5558_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acschemneuro.7b00510","volume":"9","author":"C Hicks","year":"2018","unstructured":"Hicks C, Huang P, Ramos L et al (2018) Dopamine D1-like receptor agonist and D2-like receptor antagonist (\u2212)-stepholidine reduces reinstatement of drug-seeking behavior for 3,4-methylenedioxypyrovalerone (MDPV) in rats. ACS Chem Neurosci 9:1327\u20131337. https:\/\/doi.org\/10.1021\/acschemneuro.7b00510","journal-title":"ACS Chem Neurosci"},{"key":"5558_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL et al (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.016","journal-title":"Neuropharmacology"},{"key":"5558_CR13","doi-asserted-by":"publisher","unstructured":"McClenahan SJ, Kormos CM, Gunnell MG et al (2019) Design, synthesis and biological evaluation of a bi-specific vaccine against \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.008","DOI":"10.1016\/j.vaccine.2019.10.008"},{"key":"5558_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","volume":"73","author":"ML Miller","year":"2013","unstructured":"Miller ML, Moreno AY, Aarde SM et al (2013) A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. Biol Psychiatry 73:721\u2013728. https:\/\/doi.org\/10.1016\/j.biopsych.2012.09.010","journal-title":"Biol Psychiatry"},{"key":"5558_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1037\/h0056678","volume":"35","author":"OH Mowrer","year":"1945","unstructured":"Mowrer OH, Jones H (1945) Habit strength as a function of the pattern of reinforcement. J Exp Psychol 35:293\u2013311","journal-title":"J Exp Psychol"},{"key":"5558_CR16","unstructured":"National Research Council of the National Academies (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, DC"},{"key":"5558_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.12.005","volume":"116","author":"JD Nguyen","year":"2017","unstructured":"Nguyen JD, Bremer PT, Ducime A et al (2017) Active vaccination attenuates the psychostimulant effects of \u03b1-PVP and MDPV in rats. Neuropharmacology 116:1\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.005","journal-title":"Neuropharmacology"},{"key":"5558_CR18","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neubiorev.2010.10.012","volume":"35","author":"EC O\u2019Connor","year":"2011","unstructured":"O\u2019Connor EC, Chapman K, Butler P, Mead AN (2011) The predictive validity of the rat self-administration model for abuse liability. Neurosci Biobehav Rev 35:912\u2013938. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.10.012","journal-title":"Neurosci Biobehav Rev"},{"key":"5558_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1196\/annuals.1441.027","volume":"1141","author":"FM Orson","year":"2008","unstructured":"Orson FM, Kinsey BM, Singh R et al (2008) Substance abuse vaccines. Ann N Y Acad Sci 1141:257\u2013269. https:\/\/doi.org\/10.1196\/annuals.1441.027","journal-title":"Ann N Y Acad Sci"},{"key":"5558_CR20","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","volume":"20","author":"PV Piazza","year":"2000","unstructured":"Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M (2000) Vertical shifts in self-administration dose\u2013response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci 20:4226\u20134232. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-11-04226.2000","journal-title":"J Neurosci"},{"key":"5558_CR21","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1016\/j.vaccine.2013.07.038","volume":"31","author":"D R\u00fcedi-Bettschen","year":"2013","unstructured":"R\u00fcedi-Bettschen D, Wood SL, Gunnell MG et al (2013) Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food. Vaccine 31:4596\u20134602. https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.038","journal-title":"Vaccine"},{"key":"5558_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","volume":"11","author":"C Sanchis-Segura","year":"2006","unstructured":"Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11:2\u201338. https:\/\/doi.org\/10.1111\/j.1369-1600.2006.00012.x","journal-title":"Addict Biol"},{"key":"5558_CR23","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR et al (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233:1981\u20131990. https:\/\/doi.org\/10.1007\/s00213-015-4057-0","journal-title":"Psychopharmacology"},{"key":"5558_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2012","unstructured":"Simmler LD, Buser TA, Donzelli M et al (2012) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02145.x","journal-title":"Br J Pharmacol"},{"key":"5558_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.12659\/AJCR.889381","volume":"14","author":"K Sivagnanam","year":"2013","unstructured":"Sivagnanam K, Chaudari D, Lopez P et al (2013) \u201cBath salts\u201d induced severe reversible cardiomyopathy. Am J Case Rep 14:288\u2013291. https:\/\/doi.org\/10.12659\/AJCR.889381","journal-title":"Am J Case Rep"},{"key":"5558_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0091-3057(96)00437-6","volume":"57","author":"GM Sizemore","year":"1997","unstructured":"Sizemore GM, Gaspard TM, Kim SA et al (1997) Dose\u2013effect functions for cocaine self-administration: effects of schedule and dosing procedure. Pharmacol Biochem Behav 57:523\u2013531. https:\/\/doi.org\/10.1016\/S0091-3057(96)00437-6","journal-title":"Pharmacol Biochem Behav"},{"key":"5558_CR27","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1038\/npp.2013.163","volume":"38","author":"SS Somkuwar","year":"2013","unstructured":"Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP (2013) Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions. Neuropsychopharmacol 38:2588\u20132597. https:\/\/doi.org\/10.1038\/npp.2013.163","journal-title":"Neuropsychopharmacol"},{"key":"5558_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u2018legal highs\u2019 (synthetic cathinones) in the United States. Clin Toxicol 49:499\u2013505. https:\/\/doi.org\/10.3109\/15563650.2011.590812","journal-title":"Clin Toxicol"},{"key":"5558_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Kufahl PR, Nemirovsky NE et al (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165\u2013174. https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00474.x","journal-title":"Addict Biol"},{"key":"5558_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4303\/jdar\/235967","volume":"5","author":"LR Watterson","year":"2016","unstructured":"Watterson LR, Kufahl PR, Taylor SB et al (2016) Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats. J Drug Alcohol Res 5:1\u201310. https:\/\/doi.org\/10.4303\/jdar\/235967","journal-title":"J Drug Alcohol Res"},{"key":"5558_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jat\/bkt001","volume":"37","author":"JF Wyman","year":"2013","unstructured":"Wyman JF, Lavins ES, Engelhart D et al (2013) Postmortem tissue distribution of MDPV following lethal intoxication by \u201cbath salts\u201d. J Anal Toxicol 37:182\u2013185. https:\/\/doi.org\/10.1093\/jat\/bkt001","journal-title":"J Anal Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05558-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:10:09Z","timestamp":1622761809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05558-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5558"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05558-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"8 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}